This is an exploratory study to examine the effect of iNOS inhibition in rheumatoid arthritis patients. The study involves 28 days repeat dosing with GW274150 (dose determined by the results from a previous study), prednisolone (7.5mg) or placebo.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00379990?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
